Ken Fisher
AKYA

Ken Fisher’s Akoya BioSciences AKYA Stock Holding History

Ken Fisher’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-815
Closed -$6.67K – 1163
2023
Q1 		$6.67K Buy
+815
New +$8.51K ﹤0.01% 1068

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ken Fisher's AKYA Position: Q2 2023 in Review

Ken Fisher sold out of Akoya BioSciences (AKYA) in Q2 2023, closing a stake of 815 shares — an estimated $6.67K sold.

Ken Fisher first reported a position in AKYA in Q1 2023 and held it in 1 quarter. The position peaked at $6.67K in Q1 2023. 73 funds tracked by Wall St. Rank hold AKYA as of Q2 2023.

  • Ken Fisher reported no remaining Akoya BioSciences position as of Q2 2023 after selling out during the quarter.
  • Ken Fisher sold 815 Akoya BioSciences shares in Q2 2023, an estimated $6.67K.
  • Ken Fisher first reported a position in Akoya BioSciences in Q1 2023 and held it in 1 quarter.
  • Ken Fisher's Akoya BioSciences position peaked at $6.67K in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2023.

Based on Fisher Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.